3rd mRNA-Based Therapeutics Summit Europe | Berlin, Germany | 23rd-25th January 2024 Mercure Hotel MOA Berlin, Berlin

The eagerly anticipated mRNA-Based Therapeutics Summit Europe returns to Berlin this January for the third year as Europe’s largest and most important gathering of mRNA experts.

Showcasing exclusive new data from the trailblazers and thought leaders in the field, join 250+ industry specialists including the likes of the MHRA, EMA, BioNTech, CureVac, Ziphius Vaccines, Moderna and more across 3 days to uncover groundbreaking discovery, pre-clinical and clinical insights in mRNA therapeutic and vaccine development to fast-track R and D and pipeline expansions.

Speakers: Ajan Reginald Chief Executive Officer Roquefort Therapeutics plc, Alexander Zehnder CEO CureVac, Amit Benazraf Business Development Lead Mana Bio, Anette Sommer Senior Director, Emerging Science and Innovation, Lead Oncology Europe Pfizer, Arun Kumar Preclinical Vaccines Development Lead CEPI, Carsten Rudolph CEO Ethris, Chris Cardon CEO Ziphius Vaccines, Claudia Lindemann Director – Non-Clinical Safety BioNTech SE, Covadonga Paneda Chief Operating Officer Altamira Therapeutics, Daniel Tondera Head of Biology Pantherna Therapeutics, Duccio Medini R3 Program Director Wellcome Leap, Estelle Beguin Director – Technology Research Ethris, Fernando Ulloa Montoya Head – Data and Computational Science mRNA Center of Excellence, Sanofi, Gad Berdugo Managing Partner; Strategic Advisor Explorium Capital LLC; Nutcracker Therapeutics, Jenny van Asbeck CEO Mercurna and more.